In patients with Type 2 diabetes mellitus (DM), the level of systemic inflammation, measured by C-reactive protein (CRP), may be a predictor of cardiovascular disease (CVD) and worse prognosis [1,2]. The gene discussed is CRP; the disease is cardiovascular disorder.